JY, H., Y, Z., & CW, D. Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationJY, Huang, Zhang Y, and Du CW. Continuous Anlotinib Combined with Oral Vinorelbine Has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer. Dove Medical Press.
MLA (9th ed.) CitationJY, Huang, et al. Continuous Anlotinib Combined with Oral Vinorelbine Has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer. Dove Medical Press.
Warning: These citations may not always be 100% accurate.